Why Singapore is a top choice for biopharma firms seeking global expansion

US biotech pioneer Amgen and Swiss eyecare device maker Alcon are among the companies leveraging Singapore’s R&D capabilities, talent and regional connectivity to serve Southeast Asian markets.